The summit, organized by Johnson & Johnson Diabetes Care Companies, discussed latest innovations and trends in the management of the disease to improve public health outcomes
Dubai, United Arab Emirates, June 06, 2017: With one in 11 people living with diabetes worldwide, the disease is one of the largest global health emergencies of the twenty-first century. The Middle East and North Africa (MENA) region is no exception, with four countries among the top 10 globally in terms of prevalence in this region.
As part of its commitment to diabetes management in the region, Johnson & Johnson Diabetes Care Companies (JJDCC) recently hosted its 2nd Middle East & Africa Diabetes Summit. This gathering brought together some of the leading international and regional endocrinologists and opinion leaders to discuss the latest innovations in diabetes management and their clinical implications.
In addition to discussing clinical practice guidelines, the summit also featured sessions on strengthening the relationship and improving communication between patients and healthcare professionals for better diabetes self-management.
Tamer Abbas, General Manager-Middle East, Africa, and Turkey at Johnson & Johnson Diabetes Care Companies, says employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. LifeScan and Animas are part of the Johnson & Johnson Diabetes Care Companies that keeps its fingers on the pulse of diabetes care in the region by operating in 24 countries across Middle East and Africa.”
“At Johnson & Johnson Diabetes Care Companies, our efforts are focused on patient-centered diabetes care. We create an integrated diabetes lifecycle management strategy spanning prevention, diagnosis and management,” he added.
“And this can only be done by building a strong and long-term partnership with governmental authorities, HCPs, pharmacist and nurses. We call this the Triangle of Care, where we always place patients at the center of everything we do.”
Mohamed Adel Hosni, Director of Medical & Strategic Affairs, Middle East and Africa, Johnson & Johnson Diabetes Care Companies added, “Our commitment to diabetes care is also highlighted by our efforts to enhance medical expertise, knowledge and innovation by bringing together thought leaders to discuss the future of diabetes at events such as this. We put the patient first, and our vision for the next few years is to invest heavily in educating healthcare professionals, patients and communities to empower diabetic patients with the sufficient knowledge to manage their disease through our integrated offerings.”
The latest innovations and best practices discussed during the summit and the solutions for better engagement between patients and healthcare professionals will help move diabetes care from measurement to management. Coupled with a more patient-centric approach, this ultimately can help reduce the risk of long-term complications and improve diabetes outcomes for people in the Middle East and Africa.